Phase I Study to See if a of A Combination Stem Cell Therapy is Safe and Feasible for the Treatment of Severe Coronary Ischemia

Trial Profile

Phase I Study to See if a of A Combination Stem Cell Therapy is Safe and Feasible for the Treatment of Severe Coronary Ischemia

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Apr 2014

At a glance

  • Drugs Autologous stem cell therapy (Primary)
  • Indications Angina pectoris; Coronary artery disease; Myocardial infarction
  • Focus Adverse reactions
  • Sponsors TCA Cellular Therapy
  • Most Recent Events

    • 16 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top